Daily AI-curated articles on clinical trials, FDA updates, and pharmaceutical insights.
Eli Lilly presents compelling clinical data positioning orforglipron as a superior oral alternative to existing GLP-1 therapies for Type 2 diabetes management.
FDA issues warnings to retailers selling illegal tobacco products disguised as common items, raising concerns for clinical researchers studying nicotine addiction.
GE HealthCare's infant resuscitation systems face critical oxygen concentration delivery issues due to faulty blender knobs, prompting FDA safety alert.
New Type 2 diabetes research in Austin evaluates investigational add-on medication for patients with persistent hyperglycemia despite stable treatment regimens.
Eli Lilly and Boehringer Ingelberg each slash $1B+ investments in Germany following healthcare reform targeting branded drug prices, signaling industry-wide concerns.
New FDA guidance leverages existing scientific knowledge to accelerate promising cell and gene therapies through streamlined regulatory processes.
FDA issues correction notice for KayserBett IDA pediatric care beds due to entrapment risks from unlocked hand controls, impacting clinical research facilities.
Clinical research study offers at-home participation for idiopathic hypersomnia patients, addressing treatment gaps in this underserved sleep disorder population.
